Tolerance to MOTS-c Cycling: Protocol Comparison
Different cycling approaches produce different tolerance profiles and cumulative metabolic outcomes. Here's how standard protocols compare: | Protocol | Administration Window | Washout Period | Weeks Active Per Year | Tolerance Risk | Best Use Case | Professio
This comparison does not assign a generated winner or score.
- Different cycling approaches produce different tolerance profiles and cumulative metabolic outcomes. Here's how standard protocols compare:
- | Protocol | Administration Window | Washout Period | Weeks Active Per Year | Tolerance Risk | Best Use Case | Professional Assessment ||—|—|—|—|—|—|| Standard Cycle | 4–6 weeks on | 2–4 weeks off | 32–36 weeks | Low. Allows full receptor recovery between cycles | General metabolic research, insulin sensitivity studies | Gold standard for balancing benefit duration and receptor preservation || Extended Cycle | 8–10 weeks on | 4–6 weeks off | 28–32 weeks | Moderate. Longer activation increases compensatory downregulation | Deep mitochondrial remodeling in metabolic dysfunction models | Use only when extended signaling is required; monitor for earlier plateau || Abbreviated Cycle | 3 weeks on | 1–2 weeks off | 30–36 weeks | High. Insufficient washout compounds tolerance across cycles | Not recommended except in time-limited study designs | Produces diminishing returns by cycle 3–4; avoid in long-term protocols || Continuous Administration | Ongoing | None | 52 weeks | Very high. Complete
- The comparison table shows tolerance to MOTS-c cycling isn't binary. It's a gradient determined by how aggressively you push the pathway before allowing recovery. Standard 4–6 week cycles with proper washouts preserve responsiveness indefinitely. Extended cycles work if you're willing to sacrifice total active weeks per year. Abbreviated and continuous protocols fail by month 3–4.